Cysteinyl-Leukotriene1 Receptor Is a Potent Target for the Prevention and Treatment of Human Urological Cancer

Molecular Medicine Reports - Greece
doi 10.3892/mmr_000000247
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Spandidos Publications

Related search

Estrogen Receptor-Beta Is a Potential Target for Triple Negative Breast Cancer Treatment

Oncotarget
Oncology
2018English

Erratum: Human Urotensin-Ii Is a Potent Vasoconstrictor and Agonist for the Orphan Receptor GPR14

Nature
Multidisciplinary
1999English

Is There a Role for Carbohydrate Restriction in the Treatment and Prevention of Cancer?

2013English

Prevention and Treatment of Esophageal Cancer in China: Achievements and Challenges-Prevention Is the Key

Journal of Cancer science and Clinical Oncology
2017English

The Orphan Receptor GPR17 Is Unresponsive to Uracil Nucleotides and Cysteinyl Leukotrienes

Molecular Pharmacology
Molecular MedicinePharmacology
2017English

DDX3, a Potential Target for Cancer Treatment

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2015English

The DEK Oncogene Is a Target of Steroid Hormone Receptor Signaling in Breast Cancer

PLoS ONE
Multidisciplinary
2012English

Cripto: A Target for Breast Cancer Treatment

2003English

Chronic Distress and the Vulnerable Host: A New Target for HIV Treatment and Prevention?

Neurobehavioral HIV Medicine
DermatologyPsychiatryMental HealthInfectious DiseasesBehavioral Neuroscience
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy